Cardiovascular Safety of Medication Treatments for 198 Attention-Deficit/Hyperactivity Disorder

被引:2
作者
Newcorn, Jeffrey H. [1 ]
Donnelly, Craig [2 ]
机构
[1] Mt Sinai Sch Med, New York, NY USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源
MOUNT SINAI JOURNAL OF MEDICINE | 2009年 / 76卷 / 02期
关键词
CONGENITAL CARDIAC DEFECTS; AMERICAN-HEART-ASSOCIATION; STIMULANT-DRUGS; ADOLESCENTS; STATEMENT; COMMITTEE; CHILDREN; COUNCIL; DISEASE; YOUNG;
D O I
10.1002/msj.20096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:198 / 203
页数:6
相关论文
共 13 条
[11]   Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the young congenital cardiac defects committee and the council on cardiovascular nursing [J].
Vetter, Victoria L. ;
Elia, Josephine ;
Erickson, Christopher ;
berger, Stuart ;
Blum, Nathan ;
Uzark, Karen ;
Webb, Catherine L. .
CIRCULATION, 2008, 117 (18) :2407-2423
[12]  
VILLALBA L, 2006, SAFETY REV SUDDEN DE
[13]   Stimulants and sudden death: What is a physician to do? [J].
Wilens, Timothy E. ;
Prince, Jefferson B. ;
Spencer, Thomas J. ;
Biederman, Joseph .
PEDIATRICS, 2006, 118 (03) :1215-1219